Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PTT-936 |
Synonyms | |
Therapy Description |
Limited information is currently available on PTT-936, a putative ALPK1 activator (Mar 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PTT-936 | PTT 936|PTT936 | Limited information is currently available on PTT-936, a putative ALPK1 activator (Mar 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06244992 | Phase Ib/II | PTT-936 + unspecified PD-L1 antibody PTT-936 + unspecified PD-1 antibody PTT-936 | PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors | Recruiting | USA | 0 |